A new iud insertion technique utilizing cervical priming with prostaglandin.
Cervical priming with the aid of a single 15-ME-PGF2a vaginal suppository prior to IUD insertion resulted in cervical changes which facilitated the procedure. A 0.5 mg 15(S)-15-prostaglandin F2a methyl ester vaginal suppository was administered one hour prior to the IUD insertion in all patients studied. The insertion was performed in all patients studied. The insertion was performed from seven to seventeen days following the LMP with the exception of four patients with prolonged amenorrhea. A mean increase in cervical dilatation of 2.14 mm was achieved with minimal side effects. The cervical ripening and dilatation produced by the suppository increased the ease of IUD insertion , and expanded the time frame in which an IUD insertion could be performed. The method was well tolerated by all patients and eliminated the nausea and syncope often associated with IUD insertion.
D000328:Adult; D002260:Carboprost / Q000008:administration & dosage / Q000494:pharmacology*; D002584:Cervix Uteri / Q000187:drug effects*; D003267:Contraception / Q000379:methods*; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*; D013488:Suppositories; D014621:Vagina
D011461:Prostaglandins F, Synthetic; D013488:Suppositories; D002260:Carboprost